ACM
ABBV icon

AlphaCrest Capital Management’s AbbVie ABBV Stock Holding History

AlphaCrest Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21,597
Closed -$2.9M – 6
2022
Q3 		$2.9M Sell
21,597
-5,453
-20% -$783K 0.18% 107
2022
Q2 		$4.14M Buy
27,050
+17,729
+190% +$2.71M 0.2% 97
2022
Q1 		$1.51M Sell
9,321
-10,716
-53% -$1.56M 0.08% 357
2021
Q4 		$2.71M Sell
20,037
-4,606
-19% -$544K 0.1% 273
2021
Q3 		$2.66M Sell
24,643
-111,978
-82% -$12.8M 0.14% 187
2021
Q2 		$15.4M Buy
136,621
+92,563
+210% +$10.4M 0.66% 3
2021
Q1 		$4.77M Buy
44,058
+32,545
+283% +$3.48M 0.27% 72
2020
Q4 		$1.23M Sell
11,513
-68,450
-86% -$6.58M 0.1% 250
2020
Q3 		$7M Buy
79,963
+76,951
+2,555% +$7.24M 0.76% 4
2020
Q2 		$296K Sell
3,012
-27,116
-90% -$2.39M 0.05% 637
2020
Q1 		$2.29M Buy
30,128
+12,455
+70% +$1.06M 0.28% 47
2019
Q4 		$1.56M Buy
17,673
+12,773
+261% +$1.06M 0.13% 173
2019
Q3 		$371K Sell
4,900
-42,027
-90% -$2.88M 0.02% 1041
2019
Q2 		$3.41M Buy
46,927
+33,779
+257% +$2.66M 0.3% 46
2019
Q1 		$1.06M Buy
+13,148
New +$1.08M 0.16% 159

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AlphaCrest Capital Management's ABBV Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 21,597 shares — an estimated $2.9M sold.

AlphaCrest Capital Management first reported a position in ABBV in Q1 2019 and held it in 15 quarters. The position peaked at $15.4M in Q2 2021. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 21,597 AbbVie shares in Q4 2022, an estimated $2.9M.
  • AlphaCrest Capital Management first reported a position in AbbVie in Q1 2019 and held it in 15 quarters.
  • AlphaCrest Capital Management's AbbVie position peaked at $15.4M in Q2 2021.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.